학술논문

Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis
Document Type
Article
Source
In JTO Clinical and Research Reports February 2024 5(2)
Subject
Language
ISSN
2666-3643